Jaime Vieser's most recent trade in Alaunos Therapeutics Inc was a trade of 6,400 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 6,400 | 6,400 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 3,400 | 21,159 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2025 | 250 | 250 | - | - | Series A-2 Convertible Preferred Stock | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2025 | 17,465 | 43,359 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 31 Dec 2024 | 2,182 | 26,712 (0%) | 0% | 2.0 | 4,386 | Common Stock |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 31 Dec 2024 | 818 | 25,894 (0%) | 0% | 2 | 1,636 | Common Stock |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,800 | 12,800 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 29 Nov 2022 | 1,250,000 | 1,250,000 (0%) | 0% | 0.7 | 812,500 | Common Stock |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 745,321 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 29 Sep 2021 | 100,000 | 705,321 (0%) | 0% | 1.9 | 191,000 | Common Stock |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 4,167 | 605,321 (0%) | 0% | 0 | Common Stock |